Psychiatry and Neurology, Neurology · Birmingham, AL
NPI
1215223938
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1717 6th Ave S
Birmingham, AL, 35233
Phone (800) 822-8816
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
317 services
Medicare patients, 2024
117
Average age 61
Drug cost, 2024
$916K
1,922 prescriptions
Company payments, 2025
$537
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zeenat Jaisani was code 95720 (neurologic), 92 times for 47 patients. In total Zeenat Jaisani billed 317 services in 18 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 92 | 47 | $148.96 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 47 | 30 | $9.75 | $458 |
| 95718 Neurologic | Facility | 37 | 31 | $91.60 | $3,389 |
| 99214 Office E&M - Established | Facility | 34 | 26 | $52.06 | $1,770 |
| 99215 Office E&M - Established | Facility | 16 | 13 | $100.70 | $1,611 |
| 95816 Neurologic | Facility | 14 | 14 | $41.04 | $575 |
By year: 2022 $36K for 381 services; 2023 $22K for 276 services; 2024 $25K for 317 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zeenat Jaisani prescribed most often to Medicare patients was Levetiracetam, with 286 prescriptions and refills. In total Zeenat Jaisani wrote 1,922 Medicare prescriptions that cost $916K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 286 | 455 | 49 | $10K |
| Lacosamide Generic | 265 | 304 | 42 | $39K |
| Lamotrigine Generic | 157 | 211 | 25 | $3,235 |
| Zonisamide Generic | 139 | 213 | 21 | $3,492 |
| Oxcarbazepine Generic | 96 | 110 | 13 | $5,891 |
| Xcopri Cenobamate | 94 | 94 | Under 11 | $103K |
| Clobazam Generic | 79 | 83 | Under 11 | $7,363 |
| Epidiolex Cannabidiol (Cbd) | 62 | 63 | Under 11 | $303K |
| Clonazepam Generic | 59 | 59 | Under 11 | $224 |
| Gabapentin Generic | 55 | 59 | Under 11 | $345 |
| Divalproex Sodium Er Divalproex Sodium | 48 | 73 | Under 11 | $2,471 |
| Topiramate Generic | 44 | 60 | Under 11 | $341 |
| Oxtellar Xr Oxcarbazepine | 36 | 36 | Under 11 | $37K |
| Nayzilam Midazolam | 36 | 36 | Under 11 | $24K |
| Carbamazepine Generic | 30 | 40 | Under 11 | $877 |
Brand drugs: 397 claims; generic drugs: 1,508 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zeenat Jaisani $537 ($537 in general payments such as food, travel and fees) from 1 company. The largest payer was Neuropace, Inc. with $537.
| Company | Payments | Amount |
|---|---|---|
| Neuropace, Inc. NPCE | 2 | $537 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.